同行评审直接提升放疗质量:安大略省癌症中心横断面分析
该研究分析安大略省14个癌症中心3个月内5561例根治性放疗计划的同行评审结果,发现评审比例差异大(平均70.2%),3.3%的计划建议修改,其中40.2%为重大修改。
要点
- 同行评审可识别需修改的放疗计划,其中40.2%为重大修改。
- 食管、子宫、上肢等部位修改建议率较高(5.0%-7.0%)。
核心结论
- 同行评审通过识别重要的临床和计划修改,直接影响放疗质量。
研究设计与样本
- 利用省级癌症治疗数据库,对安大略省14个癌症中心2013至2014年3个月内的根治性放疗计划进行横断面分析。
主要发现
- 各中心同行评审计划比例平均70.2%,范围40.8%-99.2%。
- 5561例根治性计划中184例(3.3%)建议修改,其中40.2%为重大修改,47.8%为轻微修改,12.0%数据缺失。
- 修改建议率因疾病部位而异(0.0%-7.0%),食管(7.0%)、子宫(6.7%)、上肢(6.3%)等部位较高。
- 左乳与右乳计划修改建议率无显著差异(3.0% vs 2.4%,95%CI分别为2.0%-4.5%和1.5%-3.8%)。
临床怎么用
- 应推广放疗前同行评审,以识别需修改的放疗计划,提升治疗质量。
局限性
- 12.0%的修改计划数据缺失,可能影响结果完整性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To describe the outcomes of peer review across all 14 cancer centers in Ontario. METHODS AND MATERIALS: We identified all peer-reviewed, curative treatment plans delivered in Ontario within a 3-month study period from 2013 to 2014 using a provincial cancer treatment database and collected additional data on the peer-review outcomes. RESULTS: Considerable variation was found in the proportion of peer-reviewed plans across the centers (average 70.2%, range 40.8%-99.2%). During the study period, 5561 curative plans underwent peer review. Of those, 184 plans (3.3%) had changes recommended. Of the 184 plans, the changes were major (defined as requiring repeat planning or having a major effect on planning or clinical outcomes, or both) in 40.2% and minor in 47.8%. For the remaining 12.0%, data were missing. The proportions of recommended changes varied among disease sites (0.0%-7.0%). The disease sites with the most recommended changes to treatment plans after peer review and with the greatest potential for benefit were the esophagus (7.0%), uterus (6.7%), upper limb (6.3%), cervix and lower limb (both 6.0%), head and neck and bilateral lung (both 5.9%), right supraclavicular lymph nodes (5.7%), rectum (5.3%), and spine (5.0%). Although the heart is an organ at risk in left-sided breast treatment plans, the proportions of recommended changes did not significantly differ between the left breast treatment plans (3.0%, 95% confidence interval 2.0%-4.5%) and right breast treatment plans (2.4%, 95% confidence interval 1.5%-3.8%). The recommended changes were more frequently made when peer review occurred before radiation therapy (3.8%) than during treatment (1.4%-2.8%; P=.0048). The proportion of plans with recommended changes was not significantly associated with patient volume (P=.23), peer-review performance (P=.36), or center academic status (P=.75). CONCLUSIONS: Peer review of treatment plans directly affects the quality of care by identifying important clinical and planning changes. Provincial strategies are underway to optimize its conduct in radiation oncology.
引用
- Rouette J, Gutierrez E, O'Donnell J, et al. Directly Improving the Quality of Radiation Treatment Through Peer Review: A Cross-sectional Analysis of Cancer Centers Across a Provincial Cancer Program. Int J Radiat Oncol Biol Phys. 2016. PMID: 28258891. doi:10.1016/j.ijrobp.2016.10.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。